Renske M. T. Ten Ham PharmD, PhD, MSc

Renske ten Ham is PhD candidate at the Division of Pharmacoepidemiology and Clinical Pharmacology of the Utrecht Institute for Pharmaceutical Sciences (UIPS). Currently she is involved in a project titled Factors associated with success and failure of Advanced Therapy Medicinal Products (ATMP) development and commercialisation in the European Union.

Renske combines her research with teaching in the European Program for Pharmacovigilance and Pharmacoepidemiology (Eu2P) in the field of medicines benefit-risk assessment. Renske received her PharmD in 2015 at Utrecht University. During her studies she did a research placement at The University of California, San Francisco (UCSF). UCSF is dedicated solely to graduate education in health and biomedical sciences and is widely regarded as one of the world's leading universities in health sciences. At UCSF Renske was involved in several mapping, utility measurement and cost-effectiveness projects.